Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Sexual Dysfunction, Physiological × Tadalafil × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1 Genitourinary 1

Conditions

Prostatic Neoplasms 3 Erectile Dysfunction 2 Sexual Dysfunction, Physiological 1

Interventions

bicalutamide 1 Testosterone Propionate 1 Testosterone 1 Tadalafil 1 Radiotherapy 1 Psychiatric Rehabilitation 1 Pilocarpine 1 Leuprolide 1 Goserelin 1 Dehydroepiandrosterone 1 Chemotherapy, Adjuvant 1 Biofeedback, Psychology 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00931528 2018-02-14

Tadalafil in Preventing Erectile Dysfunction in Patients With Prostate Cancer Treated With Radiation Therapy

Radiation Therapy Oncology Group

Phase 3 Completed

242 enrolled 13 charts

GenitourinaryOther

Prostatic Neoplasms, Sexual Dysfunction, Physiological

Data powered by HemOnc (CC BY 4.0) Colophon ⚡